Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Pediatrics
Published in: BMC Pediatrics 1/2016

Open Access 01-12-2016 | Research article

Cost-effectiveness and cost-utility analyses of hospital-based home care compared to hospital-based care for children diagnosed with type 1 diabetes; a randomised controlled trial; results after two years’ follow-up

Authors: Irén Tiberg, Björn Lindgren, Annelie Carlsson, Inger Hallström

Published in: BMC Pediatrics | Issue 1/2016

Login to get access

Abstract

Background

Practices regarding hospitalisation of children at diagnosis of type 1 diabetes vary both within countries and internationally, and high-quality evidence of best practice is scarce. The objective of this study was to close some of the gaps in evidence by comparing two alternative regimens for children diagnosed with type 1 diabetes: hospital-based care and hospital-based home care (HBHC), referring to specialist care in a home-based setting.

Methods

A randomised controlled trial, including 60 children aged 3–15 years, took place at a university hospital in Sweden. When the children were medically stable, they were randomised to either the traditional, hospital-based care or to HBHC.

Results

Two years after diagnosis there were no differences in HbA1c (p = 0.777), in episodes of severe hypoglycaemia (p = 0.167), or in insulin U/kg/24 h (p = 0.269). Over 24 months, there were no statistically significant differences between groups in how parents’ reported the impact of paediatric chronic health condition on family (p = 0.138) or in parents’ self-reported health-related quality of life (p = 0.067). However, there was a statistically significant difference regarding healthcare satisfaction, favouring HBHC (p = 0.002). In total, healthcare costs (direct costs) were significantly lower in the HBHC group but no statistically significant difference between the two groups in estimated lost production (indirect costs) for the family as a whole. Whereas mothers had a significantly lower value of lost production, when their children were treated within the HBHC regime, fathers had a higher, but not a significantly higher value. The results indicate that HBHC might be a cost-effective strategy in a healthcare sector perspective. When using the wider societal perspective, no difference in cost effectiveness or cost utility was found.

Conclusions

Overall, there are only a few, well-designed and controlled studies that compare hospital care to different models of home care. The results of this study provide empirical support for the safety and feasibility of HBHC when a child is diagnosed with type 1 diabetes. Our results further indicate that the model of care may have an impact on families’ daily living, not only during the initial period of care but for a longer period of time.

Trial registration

ClinicalTrials.gov with identity number NCT00804232, December 2008.
Literature
1.
Craig ME, Hattersley A, Donaghue KC. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes. 2009;10 Suppl 12:3–12.CrossRefPubMed
2.
Group DP. Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999. Diabet Med. 2006;23(8):857–66.CrossRef
3.
Berhan Y, et al. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes. 2011;60(2):577–81.CrossRefPubMedPubMedCentral
4.
Lowes L, Lyne P. A normal lifestyle: parental stress and coping in childhood diabetes. Br J Nurs. 1999;8(3):133–9.CrossRefPubMed
5.
Lowes L, Lyne P, Gregory JW. Childhood diabetes: parents’ experience of home management and the first year following diagnosis. Diabet Med. 2004;21(6):531–8.CrossRefPubMed
6.
Hawthorne K, et al. The experiences of children and their parents in paediatric diabetes services should inform the development of communication skills for healthcare staff (the DEPICTED Study). Diabet Med. 2011;28(9):1103–8.CrossRefPubMed
7.
American Diabetes A. Economic costs of diabetes in the U.S. In 2007. Diabetes Care. 2008;31(3):596–615.CrossRef
8.
Bolin K, et al. Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005--a register-based approach. Diabet Med. 2009;26(9):928–34.CrossRefPubMed
9.
Milton B, Holland P, Whitehead M. The social and economic consequences of childhood-onset Type 1 diabetes mellitus across the lifecourse: a systematic review. Diabet Med. 2006;23(8):821–9.CrossRefPubMed
10.
Steen Carlsson K, et al. Long-term detrimental consequences of the onset of type 1 diabetes on annual earnings--evidence from annual registry data in 1990–2005. Diabetologia. 2010;53(6):1084–92.CrossRefPubMed
11.
Wennick A, et al. Attained education and self-assessed health later in life when diagnosed with diabetes in childhood: a population-based study. Pediatr Diabetes. 2011;12(7):619–26.CrossRefPubMed
12.
Jönsson L, Hallström I, Lundqvist A. “The logic of care” – parents’ experiences of the education process when a child is newly diagnosed with type 1 diabetes. BMC Pediatr. 2012;165:11.
13.
Lowes L, Gregory JW, Lyne P. Newly diagnosed childhood diabetes: a psychosocial transition for parents? J Adv Nurs. 2005;50(3):253–61.CrossRefPubMed
14.
Wennick A, Hallstrom I. Swedish families’ lived experience when a child is first diagnosed as having insulin-dependent diabetes mellitus - An ongoing learning process. J Fam Nurs. 2006;12(4):368–89.CrossRefPubMed
15.
Sparud-Lundin C, Hallstrom I, Erlandsson LK. Challenges, strategies, and gender relations among parents of children recently diagnosed with type 1 diabetes. J Fam Nurs. 2013;19(2):249–73.CrossRefPubMed
16.
Sjöblad S. Pediatric and adolescent diabetes. National guidelines by the Swedish society for diabetology and endocrinology. 2:1 ed. Lund: Studentlitteratur; 2008.
17.
Tonyushkina KN, et al. Site of initial diabetes education does not affect metabolic outcomes in children with T1DM. Pediatr Diabetes. 2014;15(2):135–41.CrossRefPubMed
18.
Kostraba JN, et al. Increasing Trend of Outpatient Management of Children with Newly Diagnosed Iddm. Diabetes Care. 1992;15(1):95–100.CrossRefPubMed
19.
Simell T, et al. Randomized Prospective-Study of Short-Term and Long-Term Initial Stay in Hospital by Children with Diabetes-Mellitus. Lancet. 1991;337(8742):656–60.CrossRefPubMed
20.
Siminerio LM, et al. Comparing outpatient and inpatient diabetes education for newly diagnosed pediatric patients. Diabetes Educ. 1999;25(6):895–906.CrossRefPubMed
21.
Swift PGF, et al. A Decade of Diabetes - Keeping Children out-of-Hospital. Br Med J. 1993;307(6896):96–8.CrossRef
22.
Tiberg I, Hallstr I. The Influence of Initial Management and Family Stress on Metabolic Control in Children with Type 1 Diabetes. Int J Clin Med. 2010;1:6.CrossRef
23.
Clar C, Waugh N, Thomas S. Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabetes mellitus. Cochrane Database Syst Rev. 2007;2.
24.
Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996;313(7052):275–83.CrossRefPubMedPubMedCentral
25.
Gerber-Grote A, Windeler J. What is the contribution of health economic evaluations to decision-making in health care? Experiences from 7 selected countries. Z Evid Fortbild Qual Gesundhwes. 2014;108(7):358–9. 355–7.CrossRefPubMed
26.
Heintz E, et al. The impact of health economic evaluations in Sweden. Z Evid Fortbild Qual Gesundhwes. 2014;108(7):375–82.CrossRefPubMed
27.
Raftery J. Health economic evaluation in England. Z Evid Fortbild Qual Gesundhwes. 2014;108(7):367–74.CrossRefPubMed
28.
Tiberg I, et al. Metabolic control, healthcare satisfaction and costs 1 month after diagnosis of type 1 diabetes: a randomised controlled trial of hospital-based care vs. hospital-based home care. Pediatr Diabetes. 2012;13(8):625–31.CrossRefPubMed
29.
Craig P, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655. doi:10.​1136/​bmj.​a1655.
30.
31.
Tiberg I, Carlsson A, Hallstrom I. A Methodological Description of a Randomised Controlled Trial Comparing Hospital-Based Care and Hospital-Based Home Care when a Child is Newly Diagnosed with Type 1 Diabetes. Open Nurs J. 2011;5:111–9.CrossRefPubMedPubMedCentral
32.
Schulz KF, et al. CONSORT 2010 Statement Updated Guidelines for Reporting Parallel Group Randomized Trials. Obstet Gynecol. 2010;115(5):1063–70.CrossRefPubMed
33.
34.
Tiberg I, Hallström I. Translation and testing of a quality of life instrument: The PedsQL™ Family Impact Module (Översättning och testning av ett livskvalitetinstrument: The PedsQL™ Family Impact Module). Nord J Nurs Res Clin Stud/Vård i Norden. 2009;29(1):5.
35.
36.
Varni JW, et al. Evaluation of the built environment at a Children’s Convalescent Hospital: Development of the Pediatric Quality of Life Inventory (TM) parent and staff satisfaction measures for pediatric health care facilities. J Dev Behav Pediatr. 2004;25(1):10–20.CrossRefPubMed
37.
Varni JW, Quiggins DJL, Ayala GX. Development of the Pediatric Hematology/Oncology Parent Satisfaction Survey. Childrens Health Care. 2000;29(4):243–55.CrossRef
38.
Persson LO, et al. The Swedish SF-36 Health Survey II. Evaluation of clinical validity: results from population studies of elderly and women in Gothenborg. J Clin Epidemiol. 1998;51(11):1095–103.CrossRefPubMed
39.
Sullivan M, Karlsson J. The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol. 1998;51(11):1105–13.CrossRefPubMed
40.
Sullivan M, Karlsson J, Ware Jr JE. The Swedish SF-36 Health Survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med. 1995;41(10):1349–58.CrossRefPubMed
41.
Sullivan M, Karlsson J, Taft C. SF-36 Hälsoenkät: Svensk Manual och Tolkningsguide (Swedish Manual and Interpretation Guide). 2:a upplagan (2nd Edition) ed. Gothenburg: Sahlgrenska University Hospital; 2002.
42.
Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92.CrossRefPubMed
43.
Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42(9):851–9.CrossRefPubMed
44.
45.
Altman DG. Practical statistics for medical research. 1st ed. London ; New York: Chapman and Hall. xii; 1991. p. 611.
46.
Tiberg I, et al. Comparison of hospital-based and hospital-based home care at diabetes onset in children, one year after diagnosis; A randomised controlled trial. European Diabetes Nurs. 2014;11(3):4.CrossRef
47.
Tiberg I, et al. Children diagnosed with type 1 diabetes: a randomized controlled trial comparing hospital versus home-based care. Acta Paediatr. 2012;101(10):1069–73.CrossRefPubMed
48.
Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experimental designs for generalized causal inference. Boston: Houghton Mifflin. xxi; 2001. p. 623.
49.
Estabrooks CA. The conceptual structure of research utilization. Res Nurs Health. 1999;22(3):203–16.CrossRefPubMed
50.
Rycroft-Malone J. Theory and knowledge translation: Setting some coordinates. Nurs Res. 2007;56(4):S78–85.CrossRefPubMed
51.
Sparud-Lundin C, Hallstrom I. Parents’ Experiences of Two Different Approaches to Diabetes Care in Children Newly Diagnosed With Type 1 Diabetes. 2015. Qual Health Res.
52.
Hein IM, De Vries MC, Troost PW, Meynen G, Van Goudoever JB, Lindauer RJ. Informed consent instead of assent is appropriate in children from the age of twelve: Policy implications of new findings on children’s competence to consent to clinical research. BMC Med Ethics. 2015;16(1):76.CrossRefPubMedPubMedCentral
Metadata
Title
Cost-effectiveness and cost-utility analyses of hospital-based home care compared to hospital-based care for children diagnosed with type 1 diabetes; a randomised controlled trial; results after two years’ follow-up
Authors
Irén Tiberg
Björn Lindgren
Annelie Carlsson
Inger Hallström
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2016
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-016-0632-8

Other articles of this Issue 1/2016

BMC Pediatrics 1/2016 Go to the issue

Research article

Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study

Research article

Parental and staff perspectives of NICU research procedures

Research article

Explanations and information-giving: clinician strategies used in talking to parents of preterm infants

Research article

Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access

Research article

Perfusion index assessment during transition period of newborns: an observational study

Research article

Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet